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Pharmacy 553 Pharm.D.: Therapeutics III Fall 20 00
Lectures: MWThF 10 :10 -
11:00  Skaggs Bldg Rm 114
Course Coordinator: 
Instructors:
Michael Rivey = =  =  >  M. Rivey
Douglas Allington Office: 2 4 3 -6 7 9 6  
Rose Macklin Community Hosp: 728-4100  
Cathy Bartels ext. 7605
Sarah Miller Pager: 3 2 9 -6 1 2 2  
Gayle Cochran Home: 2 5 1 -3 3 6 9
Donna Beall 
Lee Ann Bradley
Material and Resources
Required Texts: DiPiro Pharmacotherapy, 4 th edition
Pray Nonprescription Product Therapeutics or APhA: Handbook
o f Nonprescription Drugs
Medical Letter on Drugs & Therapeutics
Goodman & Gilman's Pharmacological Basis o f Therapeutics
Boh Clinical Clerkship Manual
A medical dictionary
Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference
Evans: Applied Pharmacokinetics 
Young, Koda-
Kimble: Applied Therapeutics 
Herfindal, Gourley, Hart: Clinical Pharmacy and Therapeutics 
Hansten & Horn: Drug Interactions
Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text
Goals of the Course
To promote the students' understanding of common disease 
states with particular emphasis on the facets of diseases 
that are amenable to drug therapy.
To familiarize the student with the proper use of drugs in 
a clinical setting.
To develop the students' awareness of factors that should be 
considered prior to selection of a drug and the appropriate 
parameters that should be monitored for therapeutic as well 
as undesired effects.
To encourage the students' ability to problem-
solve in the 
clinical setting.
Performance Objectives
Upon completion of this course, each student shall be able to:
Relate the pathophysiology of a disease to the known or purported action of a drug.
t
Evaluate the seriousness of a disorder based on the signs and symptoms related to a 
diagnosed problem, and:
-determ ine the necessity of drug therapy,
-w h en  applicable, choose the proper drug and/or 
drug product for the situation.
Determine the place of non-pharmacologic and natural therapies, when applicable.
Tailor the drug therapy of an individual based on patient characteristics and known 
pharmacokinetics principles.
Identify potential drug-drug interactions.
Monitor the appropriate parameters of a disease to determine if the patient is 
responding positively to therapy.
Monitor for adverse drug reactions and exacerbations of underlying patient problems 
resulting from drug therapy.
Student Responsibilities and Obligations
* To attend and participate in lecture sessions.
* To do assigned readings from the texts.
* To attend Integrated Studies conferences, prepare each case in advance, to 
present a patient case, and participate in the discussion of all patient presentations.
* To perform satisfactorily on course quizzes and lecture examinations.
Therapeutics 553 Pharm.D.: Lecture Syllabus
Instructor Reading
Sept 6W  
 
Introduction/ Liver disease MPR
7Th Liver disease MPR 38
8F Renal Disease DRA 40
11M Liver disease/ quiz MPR 35
1 3W  Renal disease DRA 41
14Th Renal disease DRA 42  
15F Pain Management LAB 56
18M Pain m gm t/ quiz LAB
20W  Nausea/vomiting LAB 33, OTC 5 
21Th N&V/emetics LAB OTC 25  
22F Headache DB 57
25M  Headache DB OTC 25
27W  Oncology CLB DiPiro pp. 1957 71-  
28Th Oncology CLB pp. 2002 7-  
29F Oncology CLB pp. 2013 41-
Oct 2M Oncology CLB pp. 2 0 46 57-
4W  OFF DAY: CAREER DAY
5Th Test 1 at 8 10A M-  in SB 114; through Oncology
6F Arthritis MPR 8 3 ,8 4  
9M Arthritis MPR OTC 18 ,20  
11W  Arthritis/quiz MPR
12Th Systemic Lupus Erythematosus LRM 80
13F Contraception DB OTC 43
16M Contraception DB 76
18W  Contraception/ quiz DB
19Th Diabetes mellitis LRM 70
20F DM LRM OTC 46
23M  DM LRM
25W  DM LRM
26Th DM diet/tests/ quiz LRM
27F Osteoporosis GAC 82, OTC pp. 71 1, 713
30M  Osteoporosis GAC
Nov 1W  Menopause GAC 78
2Th Test 2 8 -
10A M  SB 114; through osteoporosis
3F Menopause GAC
